Marshall Wace, LLP X Biotech Inc. Transaction History

Marshall Wace, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.54 - $9.89 $200,241 - $436,208	-44,106 Reduced 80.66%	10,573 $54,000
Q1 2024 May 15, 2024	BUY	$4.03 - $8.13 $220,356 - $444,540	54,679 New	54,679 $444,000
Q1 2022 May 16, 2022	SELL	$8.64 - $11.71 $208,880 - $283,100	-24,176 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.95 - $16.07 $264,727 - $388,508	24,176 New	24,176 $269,000
Q2 2020 Aug 13, 2020	SELL	$10.39 - $16.07 $229,909 - $355,596	-22,128 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.89 - $24.94 $196,717 - $551,872	22,128 New	22,128 $235,000
Q2 2019 Aug 14, 2019	SELL	$6.99 - $11.27 $432,778 - $697,770	-61,914 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$5.05 - $11.62 $312,665 - $719,440	61,914 New	61,914 $682,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $118M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.